Novel combination therapy with imiquimod and sorafenib for renal cell carcinoma

2014 ◽  
Vol 21 (7) ◽  
pp. 702-706 ◽  
Author(s):  
Takashi Karashima ◽  
Toshihiro Komatsu ◽  
Mayumi Niimura ◽  
Chiaki Kawada ◽  
Masayuki Kamada ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Combination Therapy ◽  
Cell Carcinoma ◽  
Renal Cell

Lenvatinib in the management of metastatic renal cell carcinoma: a promising combination therapy?

2018 ◽  
Vol 14 (4) ◽  
pp. 461-467 ◽  
Author(s):  
Delia De Lisi ◽  
Ugo De Giorgi ◽  
Cristian Lolli ◽  
Giuseppe Schepisi ◽  
Vincenza Conteduca ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Combination Therapy ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell

scholarly journals Combination therapy using molecular-targeted drugs modulates tumor microenvironment and impairs tumor growth in renal cell carcinoma

2017 ◽  
Vol 6 (10) ◽  
pp. 2308-2320 ◽  
Author(s):  
Hiroyuki Kitano ◽  
Yasuhiko Kitadai ◽  
Jun Teishima ◽  
Ryo Yuge ◽  
Shunsuke Shinmei ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Tumor Microenvironment ◽  
Combination Therapy ◽  
Tumor Growth ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Targeted Drugs

scholarly journals Evaluating rational non-cross-resistant combination therapy in advanced clear cell renal cell carcinoma: combined mTOR and AKT inhibitor therapy

2011 ◽  
Vol 69 (1) ◽  
pp. 185-194 ◽  
Author(s):  
William S. Holland ◽  
Clifford G. Tepper ◽  
Jose E. Pietri ◽  
Danielle C. Chinn ◽  
David R. Gandara ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Combination Therapy ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Clear Cell ◽  
Inhibitor Therapy ◽  
Akt Inhibitor ◽  
Cell Renal Cell Carcinoma
Sign in / Sign up

Export Citation Format

Share Document